Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 2, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-000973.pdf 0001562180-24-000973.rtf 0001562180-24-000973.xls View HTML
February 2, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-000980.pdf 0001562180-24-000980.rtf 0001562180-24-000980.xls View HTML
February 2, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-000983.pdf 0001562180-24-000983.rtf 0001562180-24-000983.xls View HTML
February 1, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000015.pdf 0001517022-24-000015.rtf View HTML
February 1, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000016.pdf 0001517022-24-000016.rtf View HTML
January 30, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000014.pdf 0001517022-24-000014.rtf 0001517022-24-000014.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 30, 2024	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-24-019450.pdf 0001193125-24-019450.rtf 0001193125-24-019450.xls View HTML
January 18, 2024	3	Initial filing by director officer or owner of more than ten percent	0001562180-24-000527.pdf 0001562180-24-000527.rtf 0001562180-24-000527.xls View HTML
January 18, 2024	3	Initial filing by director officer or owner of more than ten percent	0001562180-24-000541.pdf 0001562180-24-000541.rtf 0001562180-24-000541.xls View HTML
January 8, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000004.pdf 0001517022-24-000004.rtf 0001517022-24-000004.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax